Elevation in white blood cell count and development of hyper LDL cholesterolemia.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
22 05 2023
22 05 2023
Historique:
received:
20
01
2023
accepted:
18
05
2023
medline:
24
5
2023
pubmed:
23
5
2023
entrez:
22
5
2023
Statut:
epublish
Résumé
To investigate the relationship between white blood cell (WBC) count and incidence of hyper-low-density lipoprotein (LDL) cholesterolemia in a population-based longitudinal study. This is a retrospective study using data of annual health check-ups for residents of Iki City, Japan. A total of 3312 residents (≥ 30 years) without hyper-LDL cholesterolemia at baseline were included in this analysis. Primary outcome was incidence of hyper-LDL cholesterolemia (LDL cholesterol levels ≥ 3.62 mmol/L and/or use of lipid lowering drugs). During follow-up (average 4.6 years), 698 participants development of hyper-LDL cholesterolemia (incidence 46.8 per 1000 person-years). Higher incidence of hyper-LDL cholesterolemia was observed among participants with higher leukocyte count (1st quartile group: 38.5, 2nd quartile group: 47.7, 3rd quartile group: 47.3, and 4th quartile group: 52.4 per 1,000 person-years, P = 0.012 for trend). Statistically significant relation was observed even after adjustment for age, gender, smoking, alcohol intake, leisure-time exercise, obesity, hypertension and diabetes: hazard ratio 1.24 (95% confidence interval 0.99 to 1.54) for 2nd quartile group, 1.29 (1.03-1.62) for 3rd quartile group and 1.39 (1.10-1.75) for 4th quartile group, compared with 1st quartile group (P for trend = 0.006). Increased WBC count was related to incidence of hyper-LDL cholesterolemia in general Japanese population.
Identifiants
pubmed: 37217577
doi: 10.1038/s41598-023-35436-6
pii: 10.1038/s41598-023-35436-6
pmc: PMC10202917
doi:
Substances chimiques
Cholesterol, LDL
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
8292Informations de copyright
© 2023. The Author(s).
Références
N Engl J Med. 2012 Jan 5;366(1):54-63
pubmed: 22216842
J Am Coll Cardiol. 2017 Jul 4;70(1):1-25
pubmed: 28527533
J Nutr. 2017 Apr;147(4):473-481
pubmed: 28179493
J Lipid Res. 2017 Jan;58(1):256-266
pubmed: 27879312
J Clin Med Res. 2020 Jul;12(7):431-435
pubmed: 32655737
J Atheroscler Thromb. 2018 Sep 1;25(9):846-984
pubmed: 30135334
PLoS One. 2012;7(11):e49875
pubmed: 23209610
Circ J. 2002 Nov;66(11):987-92
pubmed: 12419927
Hypertens Res. 2019 Sep;42(9):1235-1481
pubmed: 31375757
J Clin Med. 2021 Jul 14;10(14):
pubmed: 34300264
Arterioscler Thromb Vasc Biol. 2008 Jul;28(7):1385-91
pubmed: 18403728
Adv Nutr. 2016 Jan 15;7(1):66-75
pubmed: 26773015
J Clin Transl Endocrinol. 2014 May 13;1(2):49-53
pubmed: 29159082
Int J Mol Sci. 2014 Apr 11;15(4):6184-223
pubmed: 24733068
PLoS One. 2011;6(5):e19871
pubmed: 21625491
Intern Med. 2020 Jan 15;59(2):175-180
pubmed: 31554753
Eur Heart J. 2016 Oct 14;37(39):2999-3058
pubmed: 27567407
J Clin Med. 2021 May 01;10(9):
pubmed: 34062802
J Atheroscler Thromb. 2018 Sep 1;25(9):771-782
pubmed: 29998913
Lipids Health Dis. 2017 Oct 2;16(1):188
pubmed: 28969682
Arterioscler Thromb Vasc Biol. 2019 May;39(5):965-977
pubmed: 30866659
J Hum Hypertens. 2019 Dec;33(12):873-878
pubmed: 31113986
PLoS One. 2021 Feb 2;16(2):e0246304
pubmed: 33529192
Arch Intern Med. 2011 Nov 28;171(21):1920-7
pubmed: 22123800
Int J Epidemiol. 2007 Jun;36(3):600-9
pubmed: 17317693
Arterioscler Thromb Vasc Biol. 2012 Aug;32(8):1771-6
pubmed: 22815343
Diabetologia. 2015 May;58(5):886-99
pubmed: 25725623